Hugh Grant Edmiston

Scottish Enterprise operates economic development agencies. It works with enterprise, innovation, and investment agencies. The firm has partnership with universities, colleges, local authorities, and other public sector bodies to improve the government's economic strategy. The company is headquartered in Glasgow, the United Kingdom.

TTP Group Plc engages in the provision of technology and product development services through its subsidiaries. It helps large and small companies to recognize, create and exploit new technologies. The company in October 1987 and is headquartered in Royston, the United Kingdom.

Genomia Management Ltd. (GML) is an independent Scotland-based venture capital firm which was established in 2004 with funding from the Office of Science and Technology, Public Sector Research Exploitation Fund. Located in Edinburgh, GML manages the Genomia Fund, dedicated to supporting the early-stage commercial development of life science research from institutes including the Institute for Animal Health, Moredun Research Institute, Roslin Institute, Rowett Research Institute and the Scottish Agriculture College.

Fios Genomics Ltd. provides genomic and bioinformatics data analysis services. It offers access to a combined resource of in-house bioinformaticians, statisticians and biologists working together to analyze, interpret genomic, transcriptomic and proteomic data. The company was founded by Peter Ghazal in 2008 and is headquartered in Edinburgh, the United Kingdom.

Knowledge Transfer Network Ltd. is a British company that helps organizations interested in innovation in the creative industries to access funding and make connections. The private company provides the rapid transfer of high-quality information on technologies, markets, funding, and partnering opportunities to support UK innovation. The company is based in Islington, UK, and the CEO of the company is Alicia Greated. The company offers knowledge transfer partnerships (KTPs) to build long-lasting and mutually beneficial collaborations between the working and learning worlds.

Higher Education Statistics Agency Ltd. is a trusted source of data and analysis for publicly funded higher education in the UK. The private company is based in Cheltenham, UK. The British company collects, process, and publish data about higher education, playing a key role in supporting and enhancing the competitive strength of the sector. HESA's data analytics services are now delivered by Jisc, and their data analytics team has integrated with Jisc's newly established data analytics directorate. The CEO of the company is Robert Bryan Phillpotts.

Censo Biotechnologies Ltd. operates as stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. It offers human bio-sample procurement, IPSC generation & genome editing, IPSC differentiation, assay development and screening services. The company is headquartered in Midlothian, the United Kingdom.

Part of The University of Edinburgh, UoE Deaconess Ltd. is an investment and British student accommodation property company. The company is based in Leeds, UK. Founded in 2011.

Part of The University of Edinburgh, UoE Estates Services Co. Ltd. is a British company that generates electricity and constructs civil engineering projects. The company is based in Edinburgh, UK and was founded in 1996.

Roslin Technologies Ltd. engages in the provision of agriculture biotechnology solutions. It offers genome sequencing, genotyping, gene editing, transgenics, phenotyping, and bioinformatics. The company is headquartered in Midlothian, the United Kingdom.

Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022.